Raymon Heather
SEC CIK 2028466 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | SVP, Research, Development | 148.2K | — | $27.9K | 8 | 2024-09-12 | 2026-05-19 |
Most active insiders at ARTV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $92.68M | — |
| 2 | GC Corp. | 10% | $16.50M | — |
| 3 | Aslan Fred | Pres, CEO, Dir | — | $1.38M |
| 4 | Banerjee Subhashis | Chief Medical Off | — | $179.5K |
| 5 | Horan Christopher | Chief Tech Ops Off | — | $178.7K |
| 6 | Bush Jennifer | COO, CLO, Secy, Compliance Off | — | $172.8K |
| 7 | Raymon Heather | SVP, Research, Development | — | $27.9K |
| 8 | Krishnamohan Neha | CFO | — | — |
| 9 | Miralles Gines Diego | Pres, Head of R, D | — | — |
| 10 | Huston Thad Allen | CFO | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 21:52 | 2026-05-19 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | S - Sale | $9.01 | -3,095 | 148.2K | -2% | -$27.9K | |
| 2026-02-18 | 2026-02-15 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +46.0K | 152.8K | +43% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | F - Tax | $4.00 | -1,521 | 151.3K | -1.0% | -$6,084 | |
| D | 2025-12-12 | 2025-12-12 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +67.3K | 106.8K | +170% | $0 |
| 2025-11-17 | 2025-11-15 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | F - Tax | $3.25 | -1,375 | 39.6K | -3% | -$4,469 | |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | F - Tax | $2.56 | -2,384 | 41.0K | -5% | -$6,094 |
| 2025-02-28 | 2025-02-26 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +33.4K | 43.4K | +334% | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Artiva Biotherapeutics, Inc. | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations